Quad-Cities Investment Group’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Quad-Cities Investment Group’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-530	Closed	-$19K	–	715
2019 Q3	$19K	Hold	530	–	–	0.02%	500
2019 Q2	$21K	Hold	530	–	–	0.02%	491
2019 Q1	$22K	Hold	530	–	–	0.02%	475
2018 Q4	$19K	Hold	530	–	–	0.02%	496
2018 Q3	$26K	Hold	530	–	–	0.02%	473
2018 Q2	$23K	Buy	+530	New	+$22.3K	0.02%	499

Other funds holding XPH

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.99B AUM 30.41% 1-Year Est. Return

HCIA

Hochman Cole Investment Advisors Deerfield, Illinois $255M AUM 23.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Quad-Cities Investment Group's XPH Position: Q4 2019 in Review

Quad-Cities Investment Group sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q4 2019, closing a stake of 530 shares — an estimated $19K sold.

Quad-Cities Investment Group first reported a position in XPH in Q2 2018 and held it in 6 quarters. The position peaked at $26K in Q3 2018. 75 funds tracked by Wall St. Rank hold XPH as of Q4 2019.

Quad-Cities Investment Group reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q4 2019 after selling out during the quarter.
Quad-Cities Investment Group sold 530 State Street SPDR S&P Pharmaceuticals ETF shares in Q4 2019, an estimated $19K.
Quad-Cities Investment Group first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q2 2018 and held it in 6 quarters.
Quad-Cities Investment Group's State Street SPDR S&P Pharmaceuticals ETF position peaked at $26K in Q3 2018.
75 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q4 2019.

Based on Quad-Cities Investment Group's 13F filing for Q4 2019, filed 28 Jan 2020.